Marizomib for central nervous system-multiple myeloma-Reference-Cited by-同舟云学术

Marizomib for central nervous system-multiple myeloma

Published:2017-04 Issue:2 Volume:177 Page:221-225
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Badros Ashraf¹,Singh Zeba¹,Dhakal Binod²,Kwok Young¹,MacLaren Ann³,Richardson Paul⁴,Trikha Mohit³,Hari Parameswaran²

Affiliation:

1. M&S Greenebaum Cancer Center; University of Maryland Medical Center; Baltimore MD USA

2. Division of Hematology/Oncology; Medical College of Wisconsin; Milwaukee WI USA

3. Triphase Accelerator; San Diego CA USA

4. Dana-Farber Cancer Institute; Boston MA USA

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bjh.14498/fullpdf

Reference10 articles.

1. Patterns of central nervous system involvement in relapsed and refractory multiple myeloma;Abdallah;Clinical Lymphoma Myeloma and Leukemia,2014

2. Investigation of pharmacodynamics and predictive biomarkers to define response to proteasome inhibitor marizomib in glioma [abstract]. In: Proceedings of the 107th Annual Meeting of the American Association for Cancer Research; 2016 Apr 16-20; New Orleans, LA. Philadelphia (PA): AACR;Bota;Cancer Research,2016

3. Marizomib activity as a single agent in malignant gliomas: ability to cross the blood-brain barrier;Di;NeuroOncology,2016

4. Myeloma of the central nervous system: association with high-risk chromosomal abnormalities, plasmablastic morphology and extramedullary manifestations;Fassas;British Journal of Haematology,2002

5. Emergence of central nervous system myeloma in the era of novel agents;Gangatharan;Hematological Oncology,2012

Cited by 53 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antiproliferative metabolites against glioma cells from the marine-associated actinomycete Streptomyces sp. ZZ735;Fitoterapia;2024-10

2. Cardiotoxicity of Anticancer Drugs: Molecular Mechanisms, Clinical Management and Innovative Treatment;Drug Design, Development and Therapy;2024-09

3. Marizomib for patients with newly diagnosed glioblastoma: A randomized phase 3 trial;Neuro-Oncology;2024-03-19

4. A Rare Case of Daratumumab-Associated Encephalopathy in Multiple Myeloma;Immunotherapy;2024-03-05

5. Marine-Derived Anticancer Agents Targeting Apoptotic Pathways: Exploring the Depths for Novel Cancer Therapies;Marine Drugs;2024-02-28